Show cause notice to KV Thomas. Must reply within a week. The action was taken for violating the party ban and attending the CPM seminar. The decision was taken by the disciplinary committee chaired by AK Antony. The disciplinary committee considered the complaint filed by KPCC president K Sudhakaran. Tariq Anwar said the decision would be taken following receiving a reply from KV Thomas. Watch the video story:
Daily Archives
April 11, 2022
On April 10, the Day of the Scientific Researcher was celebrated, in honor of one of the most relevant figures in the history of our science: the Dr. Bernardo Houssay, winner of the Nobel Prize in Medicine and Physiology and a world leader in the area. Our country was and continues to be the cradle of hundreds of researchers who, with great dedication, make scientific activity their career choice.
In the field of the pharmaceutical industry, the role of scientists is directly related to Clinical Research, an area aimed at discovering new therapeutic options to cover unmet medical needs. In recent decades, the innovations developed from scientific work have made it possible to eradicate smallpox and polio, cure pathologies such as hepatitis C or develop treatments for certain diseases, such as certain types of cancer or HIV. Recently, it allowed us to develop vaccines and treatments that gave us the opportunity to meet our loved ones once more and open the doors of schools, universities, homes and workplaces.
Argentina today has enormous potential, with the ability to become an important international benchmark
Likewise, the experience of the pandemic allowed the community in general to become more aware of this type of clinical study, and today it is more aware of how crucial research and development is in the field of health and as a tool so that we can lead a full life. According to a recent study carried out by the Argentine Chamber of Medicinal Specialties (Caeme), 7 out of 10 people would participate in research of this type.
In this sector, Argentina today has enormous potential, with the capacity to become an important benchmark at the international level: through the improvement of processes and the implementation of more competitive times, we have managed to become the country with the highest rate of studies highest per million inhabitants in the region, with an important position, as well as the excellent quality of medical researchers. If we continue along this line, we can continue to strengthen ourselves to attract more research, continue training our professionals, generate quality employment, promote foreign exchange earnings and provide services abroad.
The experience of the last two years has allowed us to incorporate new technologies in a more strategic way, improve processes and ensure that therapeutic solutions reach people at an unparalleled speed.
It is with this perspective that we invest year following year in Research and Development projects in different therapeutic areas: globally we have 89 molecules in different phases of research and in Argentina we have 38 projects that include the areas of Vaccines and Infectious Diseases, Oncology, Rare Diseases, Inflammatory Diseases (Rheumatology) and Cardiology. This scientific work, which we develop with our research teams and with different partners around the world, opens up new horizons for us to treat and cure diseases that, in many cases, only have treatments aimed at palliating their symptoms.
We are in a unique moment to develop scientific work: the experience of the last two years has allowed us to incorporate new technologies in a more strategic way, improve processes and ensure that therapeutic solutions reach people at an unparalleled speed. Today, more than ever, it is clear that science is essential for the progress of global health and, consequently, for the economies of the world to continue to progress. We have the talents and the tools, it only remains to articulate them so that they can find each other and empower themselves.
KEEP READING:
Yasmine Rais started filming the movie “The Mazinger Plan” (directed by Ramy Rizkallah) two days ago in Cairo, and she is starring alongside her compatriot, actor Hamdi Al-Mirghani. In this context, the author of the work, writer Walid Khairy, confirmed that the Egyptian film revolves around a satirical comedy framework, and a group of writers participated in it, and the actors gathered Bayoumi Fouad and Mahmoud Hafez.
In this context, Yasmine published on her social media pages a video announcing the launch of filming.
On the other side, the Egyptian actress recently had her first theatrical experience through “The Descendants of Raya and Sakina” (written by Ahmed Shaker and Mustafa Hosni, directed by Sameh Bassiouni), which was recently shown in Saudi Arabia.
For his part, Hamdi Al-Mirghani continues filming the events of his role in the movie “Bahebak” (written and directed by Tamer Hosni), starring Tamer Hosni, Hana Al-Zahid, Medhat Ismail, Amr Sahsah and Hoda Al-Mufti.
It is noteworthy that Yasmine recently announced her divorce from her husband, director Hadi El Bagoury, following a marriage that lasted nearly ten years. The actress gained wide fame following director Muhammad Khan chose her to star in the movie “Factory Girl”, which was shown in 2014. From that day on, her successes were repeated on both small and large screens.
Taiwan stock back test Wanqi three major legal persons sold over 40.566 billion yuan and foreign capital withdrew 34 billion yuan | Anue Juheng
written by Alexandra Hartman Editor-in-Chief
The closure of Shanghai and Kunshan in China has been extended, and the market is worried that it will further impact the supply chain of Taiwan factories. The electronics community of Taiwan stocks is rumbling today (11), and weight stocks such as wafer giants fell to the ground. Finance and transmission production also weakened.weighted indexIt ended down 236 points and closed at 17,048 points, with a transaction value of 299.5 billion yuan. The three major legal persons sold a total of over 40.566 billion yuan, of which foreign capital continued to withdraw 34 billion yuan.
Observing the changes in the capital of the three major legal persons today, foreign capital slashed 34.041 billion yuan, which is 5 consecutive sales; Iowan added more than 1.516 billion yuan, which is 8 consecutive buys; self-operated traders also rarely sold 8.039 billion yuan. The three legal persons sold a total of over 40.566 billion yuan.
The epidemic situation in China is severe, and the closure order of Kunshan, an important town of Taiwanese electronics industry, has been extended to the 12th. It is difficult to resume work even on the eve of the May Day holiday. PCB, connector, Netcom and other industries bear the brunt, and the legal person is worried that it will impact the second quarter financial forecast target of relevant Taiwan factories After the achievement, the PCB group is under selling pressure today, especially the ABF carrier board Sanxiong, Nandian, Xinxing fell 7-8%, Jingshuo fell by nearly half, and others include Dingying, Huatong, Taiwan Optoelectronics, Jingchengke , Jialianyi and other declines are quite heavy.
The two giants of the wafer fell to the ground, TSMC (2330-TW) shares fell more than 1%, closing at the lowest price of 558 yuan at the end, and the market value fell to 14.47 trillion yuan; UMC fell below the 50 yuan barrier due to the news that the mature wafer foundry process was frozen, and ended down 3.6%, closing at 48.2 yuan, a record high. New lows in the past 1 year; electronic weight stocks such as Yageo, Delta, Realtek, Largan, AUO, ASE Investment and Control are all under heavy selling pressure.
The group of passive components was rumbling, and the stock price of Yageo, a leading domestic manufacturer, fell 3.6%, and fell below the 400 yuan level, hitting a new low in 1 year and 5 months. Huarong’s decline was heavy; IC design was also attacked, and Jinghao Technology fell to the limit. Holtek, Nuvoton, Zhiyuan, AsiaInfo, Phison, Huaxun, and Genesys all fell by more than half the limit.
However, the biotech group continued to be supported by buying, including Baoling Fujin, Sinochem, Arnold & Nova, Quanyu Bio-KY, ABC-KY, Taibo, Shenghuake, etc., all of which turned on the daily limit; The prices of potash fertilizers and urea have soared, and agricultural and gold concept stocks have also become bullish indicators on the disk.